ReviewClinical ophthalmology (Auckland, N.Z.)2020
Icare Home Tonometer: A Review of Characteristics and Clinical Utility.
Review in Clinical ophthalmology (Auckland, N.Z.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- The impact of iCare HOME tonometry on clinical decision-making in glaucoma management: a retrospective observational study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Home monitoring devices for glaucoma.Indian journal of ophthalmology · 2026Review
- Validation of the EYEMATE-SC Suprachoroidal Pressure Transducer for Telemetric Measurement of Intraocular Pressure in Normal Ex Vivo Canine and Equine Globes-Preliminary Results.Veterinary ophthalmology · 2025Article
- Elevated intraocular pressure associated with sauna use: A case report.American journal of ophthalmology case reports · 2025Article
- Patient Perspectives on Home Tonometer Usage for Glaucoma.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
- The relationship between intraocular pressure and glaucoma: An evolving concept.Progress in retinal and eye research · 2024Review
- Comparison of intracompartment pressure changes in tibial plateau fractures and controlled people: A pilot study.PloS one · 2024Article
- Clinical utility, feasibility of home tonometry using iCare HOME by glaucoma patients.Indian journal of ophthalmology · 2023Article
- Repeated Measurements Are Necessary for Evaluating Accurate Diurnal Rhythm Using a Self-Intraocular Pressure Measurement Device.Journal of clinical medicine · 2023Article
- Perspectives on the Home Monitoring of Macular Disease.Ophthalmology and therapy · 2023Article
- iCare® Home vs Goldmann applanation tonometry: Agreement of methods and comparison of inter-observer variation at a tertiary eye centre.European journal of ophthalmology · 2023Article
- Comparison of intraocular pressure readings with Perkins, Tonopen, iCare 200, and iCare Home to manometry in cadaveric eyes.International journal of ophthalmology · 2022Article
- COVID-19 and Use of Teleophthalmology (CUT Group): Trends and Diagnoses.Ophthalmology · 2021Article
- How to Measure Intraocular Pressure: An Updated Review of Various Tonometers.Journal of clinical medicine · 2021Review
- Early diagnostics and interventional glaucoma.Therapeutic advances in ophthalmologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Icare HOME (TA022, Icare Oy, Vanda, Finland) is rebound tonometer recently approved by the US Food and Drug Administration in March 2017 designed for self-measurement of intraocular pressure (IOP). IOP remains a major modifiable risk factor for glaucoma progression; however, IOP measurements typically occur through single office measurements on Goldmann applanation tonometry (GAT) and do not always reveal the complete picture of patient's IOP patterns and daily fluctuations, which are important for accurate diagnosis and evaluation. Numerous studies have now compared the efficacy of the Icare HOME to that of GAT. The objective of this article is to review the existing literature surrounding the Icare HOME tonometer and its efficacy as a self-tonometer in comparison to GAT. The available literature has shown promising results in its accuracy of measuring IOP but suggests cautious usage in patients with central corneal thicknesses or IOP ranges that are outside of a certain range. This article will also provide details and example cases for when the Icare HOME may be most clinically useful.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.